JIANGSU HENGRUI PHARM CO Market Sentiment
Benzinga reports on the market sentiment for JIANGSU HENGRUI PHARMACEUTICALS CO LTD.
Results for "Hengrui Pharma"
3 stories found
Bristol Myers Squibb, Hengrui Pharma Ink $15 Billion Licensing Deal
Bristol Myers Squibb and China's Hengrui Pharma have signed a licensing deal valued at up to $15.2 billion. This agreement involves a significant collaboration between the two pharmaceutical companies.
China's Hengrui Pharmaceutical Seals US$15.2 Billion Deal with Bristol Myers Squibb
Jiangsu Hengrui Pharmaceutical, China's largest drug company, has entered into a global collaboration and licensing agreement with US pharmaceutical giant Bristol Myers Squibb (BMS) valued at up to US$15.2 billion.